These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16236499)

  • 1. Optimization of CCR4 antagonists: side-chain exploration.
    Purandare AV; Wan H; Gao A; Somerville J; Burke C; Vaccaro W; Yang X; McIntyre KW; Poss MA
    Bioorg Med Chem Lett; 2006 Jan; 16(1):204-7. PubMed ID: 16236499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core exploration in optimization of chemokine receptor CCR4 antagonists.
    Purandare AV; Wan H; Somerville JE; Burke C; Vaccaro W; Yang X; McIntyre KW; Poss MA
    Bioorg Med Chem Lett; 2007 Feb; 17(3):679-82. PubMed ID: 17098428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and initial evaluation of 4-N-aryl-[1,4]diazepane ureas as potent CXCR3 antagonists.
    Cole AG; Stroke IL; Brescia MR; Simhadri S; Zhang JJ; Hussain Z; Snider M; Haskell C; Ribeiro S; Appell KC; Henderson I; Webb ML
    Bioorg Med Chem Lett; 2006 Jan; 16(1):200-3. PubMed ID: 16213722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonists.
    Newhouse B; Allen S; Fauber B; Anderson AS; Eary CT; Hansen JD; Schiro J; Gaudino JJ; Laird E; Chantry D; Eberhardt C; Burgess LE
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5537-42. PubMed ID: 15482919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bipiperidinyl carboxylic acid amides as potent, selective, and functionally active CCR4 antagonists.
    Kuhn CF; Bazin M; Philippe L; Zhang J; Tylaska L; Miret J; Bauer PH
    Chem Biol Drug Des; 2007 Sep; 70(3):268-72. PubMed ID: 17718722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of eosinophil influx into the lung by small molecule CC chemokine receptor 3 antagonists in mouse models of allergic inflammation.
    Das AM; Vaddi KG; Solomon KA; Krauthauser C; Jiang X; McIntyre KW; Yang XX; Wadman E; Welch P; Covington M; Graden D; Yeleswaram K; Trzaskos JM; Newton RC; Mandlekar S; Ko SS; Carter PH; Davies P
    J Pharmacol Exp Ther; 2006 Jul; 318(1):411-7. PubMed ID: 16614169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Amino-1-alkyl-cyclopentane carboxamides as small molecule antagonists of the human and murine CC chemokine receptor 2.
    Butora G; Jiao R; Parsons WH; Vicario PP; Jin H; Ayala JM; Cascieri MA; Yang L
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3636-41. PubMed ID: 17482462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent CCR4 antagonists: synthesis, evaluation, and docking study of 2,4-diaminoquinazolines.
    Yokoyama K; Ishikawa N; Igarashi S; Kawano N; Masuda N; Hattori K; Miyazaki T; Ogino S; Orita M; Matsumoto Y; Takeuchi M; Ohta M
    Bioorg Med Chem; 2008 Sep; 16(17):7968-74. PubMed ID: 18694645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule antagonists of the CC chemokine receptor 4 (CCR4).
    Burdi DF; Chi S; Mattia K; Harrington C; Shi Z; Chen S; Jacutin-Porte S; Bennett R; Carson K; Yin W; Kansra V; Gonzalo JA; Coyle A; Jaffee B; Ocain T; Hodge M; LaRosa G; Harriman G
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3141-5. PubMed ID: 17395464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel non-peptide CXCR4 antagonists by ligand-based design approach.
    Ueda S; Kato M; Inuki S; Ohno H; Evans B; Wang ZX; Peiper SC; Izumi K; Kodama E; Matsuoka M; Nagasawa H; Oishi S; Fujii N
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4124-9. PubMed ID: 18539453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Brogan JB; Mo R; Lo YC; Yang G; Miller PB; Scherle PA; Molino BF; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2009 Feb; 19(3):597-601. PubMed ID: 19131247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and optimization of a novel Neuromedin B receptor antagonist.
    Fu J; Shuttleworth SJ; Connors RV; Chai A; Coward P
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4264-7. PubMed ID: 19553112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of chemokine receptor CCR4 antagonist.
    Purandare AV; Gao A; Wan H; Somerville J; Burke C; Seachord C; Vaccaro W; Wityak J; Poss MA
    Bioorg Med Chem Lett; 2005 May; 15(10):2669-72. PubMed ID: 15863339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonists.
    Allen S; Newhouse B; Anderson AS; Fauber B; Allen A; Chantry D; Eberhardt C; Odingo J; Burgess LE
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1619-24. PubMed ID: 15026036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
    Andrews G; Jones C; Wreggett KA
    Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists.
    Batt DG; Houghton GC; Roderick J; Santella JB; Wacker DA; Welch PK; Orlovsky YI; Wadman EA; Trzaskos JM; Davies P; Decicco CP; Carter PH
    Bioorg Med Chem Lett; 2005 Feb; 15(3):787-91. PubMed ID: 15664858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and structure-activity relationship of novel CCR2 antagonists.
    Kothandaraman S; Donnely KL; Butora G; Jiao R; Pasternak A; Morriello GJ; Goble SD; Zhou C; Mills SG; Maccoss M; Vicario PP; Ayala JM; Demartino JA; Struthers M; Cascieri MA; Yang L
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1830-4. PubMed ID: 19237282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8).
    Ghosh S; Elder A; Guo J; Mani U; Patane M; Carson K; Ye Q; Bennett R; Chi S; Jenkins T; Guan B; Kolbeck R; Smith S; Zhang C; LaRosa G; Jaffee B; Yang H; Eddy P; Lu C; Uttamsingh V; Horlick R; Harriman G; Flynn D
    J Med Chem; 2006 May; 49(9):2669-72. PubMed ID: 16640325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and orally bioavailable CCR4 antagonists: Synthesis and structure-activity relationship study of 2-aminoquinazolines.
    Yokoyama K; Ishikawa N; Igarashi S; Kawano N; Masuda N; Hamaguchi W; Yamasaki S; Koganemaru Y; Hattori K; Miyazaki T; Ogino S; Matsumoto Y; Takeuchi M; Ohta M
    Bioorg Med Chem; 2009 Jan; 17(1):64-73. PubMed ID: 19081254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine.
    Richardson SK; Newton SB; Bach TL; Budgin JB; Benoit BM; Lin JH; Yoon JS; Wysocka M; Abrams CS; Rook AH
    Am J Hematol; 2007 Sep; 82(9):792-7. PubMed ID: 17546636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.